Clinical Trial Supply and Logistics Market, By Service (Manufacturing, Packaging and Labeling, and Distribution), By End User (Pharmaceutical, Medical Devices, and Biologics), and by Region - Global Forecast to 2026

  • Published On : Jun 2018 |
  • Pages : 173 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Clinical Trial Supply and Logistics Market – Insights

Clinical trial supply and logistics is a management that is responsible for providing clinical supplies needed for clinical studies of drugs or medical devices in accordance with protocol and applicable regulatory requirements. This process involves oversight of the planning, packaging, forecasting, labeling, sourcing, distribution, and clinical supplies for government and commercial sponsors whose studies are in phase 1-4 clinical trials. Clinical trial suppliers integrate with many third party vendors and technicians to verify whether study drugs available are in sufficient quantity and quality at various stages of clinical distribution. This management, in terms of drug supply, offers full traceability from manufacturing to dispensation and destruction, which in turn reduces risks such as expiration or out of stock of products.

The global clinical trial supply and logistics market size was valued at US$ 14.95 Bn in 2017 and is expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026).

Fig: Global Clinical Trial Supply and Logistics Market, By Region (US$ Mn)

clinical trial supply and logistics market

Source: Coherent Market Insights Analysis (2018)

Clinical Trial Supply and Logistics Market Drivers

Quantity of ancillary supplies and diverse vendors to produce those supplies have significantly increased in the market, owing to rising demand for developing and producing clinical supplies from end user manufacturers or investigators for global studies in a cost-efficient manner. According to an article published in the Applied Clinical Trials website, 2016, there are around 40,000 unique investigators worldwide conducting at least one FDA-regulated clinical trial. Furthermore, increasing prevalence of cancer across the globe is providing new opportunities for global biopharmaceutical research community, and clinical trial supply and logistics management to bring the respective drug to the market sooner by navigating the complex clinical & regulatory environment. According to the World Health Organization (WHO), there were around 555,318 new cases of cancer in 2012 in the Middle East. The region is expected to witness around 961,098 cases by 2030, which will be the highest number of cancer cases among other regions in the world.

Change in regulations related to clinical trials is also expected to have some impact on the market. In 2013, the European Union enacted good distribution practices (GDPs), which are now becoming a globally adopted guidance. Although the timeline is still under discussion, new regulations for clinical trials that are conducted in the European Union will be revealed in 2019. The new regulations could potentially impact the supply chain, although it is primarily geared to existing good manufacturing practices (GMPs) for products covered by an existing directive.

Biologics are also expected to witness steady growth, owing to increasing research activities such as development of nanoparticle-based drug delivery systems in the field of genetics and biotechnology. For instance, in May 2018, Catalent Pharma Solutions collaborated with Valerius Biopharma AG, a Swiss biopharmaceutical company, for the development and manufacturing of Valerius’ biosimilar products, as alternatives to high-priced biologics. This is expected to boost clinical trial supply and logistics market growth over the forecast period.

Clinical Trial Supply and Logistics Market Regional Outlook

On the basis of region, the global clinical trial supply and logistics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to hold a dominant position in this market, owing to the adoption of technologically advanced products, well established regulatory agencies, and presence of major Contract Research Organizations (CRO’s) and biopharmaceutical company’s hubs. Moreover, factors such as improved healthcare facilities and better reimbursement scenario are also driving growth of clinical trial supply and logistics market in this region. The number of new vendors trying to enter the healthcare industry are expected to increase over the forecast period, as there are many niche market players trying to leverage the market share through new inventories in medical devices and drugs. Also, they will require clinical trial supply management to cut down costs across all aspects of the business, by reducing internal capacity - in terms of site maintenance and employee headcount. Thus, emerging economies such as Asia Pacific and Latin America has huge potential for market growth, and is projected to be the fastest growing region over the forecast period.

Some of the key players operating in the global clinical trial supply and logistics market include Catalent Pharma Solutions, Inc., Almac Group, Movianto, Patheon, Inc., PCI Pharma Distribution, Sharp Packaging Distribution, PAREXEL International Corporation, Marken, KLIFO A/S, and Biocair.

Continuous emphasis by the manufacturers towards balancing shipment and supply costs, optimizing production and packaging and minimizing overage and avoiding shortages, are propelling the demand for efficient solutions for clinical trial supply and logistics. Technological advancements will also drive the growth in clinical trial supply and logistics market, providing efficient planning and real-time data analysis to improve supply chains mid-trial. Drug pooling for multi-trial programmes will also augment the demand for regional depot network with strong transport networks to trial sites.

Market Dynamics

Increase in number of registered clinical trials across the regions is also expected to spur the demand of clinical trial supply and logistics market during the forecast period. Various online sources suggest that the Brazil holds the second most registered clinical trials among the BRIC (Brazil, Russia, India and China) countries, with a share of approximately 2% of the global volume. Furthermore, vendors are also focussing on launching different clinical programs to market their services and attract more clients and government to partnership with them. For instance, in June 2018, Bionical Group Ltd launched Bionical-Clinical Early Access Programs (EAP) which connect established and successful Clinical Research Organization to support large and small scale Pharma and Biotech industries enabling, appropriate treatment access to patients in desperate need.

Key features of the study:

  • This report provides in-depth analysis of the clinical trial supply and logistics market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2016 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global clinical trial supply and logistics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Catalent Pharma Solutions, Inc., Almac Group, Movianto, Patheon, Inc., PCI Pharma Distribution, Sharp Packaging Distribution, PAREXEL International Corporation, Marken, KLIFO A/S, and Biocair.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future offerings, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global clinical trial supply and logistics market report caters to various stakeholders in this industry, including investors, service providers, distributors and suppliers for clinical trial supply and logistics market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Clinical Trial Supply and Logistics Market, By Service:
    • Manufacturing
    • Packaging and Labelling
    • Distribution
  • Global Clinical Trial Supply and Logistics Market, By End User:
    • Pharmaceutical
    • Medical Devices
    • Biologics
  • Global Clinical Trial Supply and Logistics Market, By Region:
    • North America Clinical Trial Supply and Logistics Market
      • By Country:
        • U.S.
        • Canada
      • By Service:
        • Manufacturing
        • Packaging and Labelling
        • Distribution
      • By End User:
        • Pharmaceutical
        • Medical Devices
        • Biologics
    • Europe Clinical Trial Supply and Logistics Market
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Service:
        • Manufacturing
        • Packaging and Labelling
        • Distribution
      • By End User:
        • Pharmaceutical
        • Medical Devices
        • Biologics
    • Asia Pacific Clinical Trial Supply and Logistics Market
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Service:
        • Manufacturing
        • Packaging and Labelling
        • Distribution
      • By End User:
        • Pharmaceutical
        • Medical Devices
        • Biologics
    • Latin America Clinical Trial Supply and Logistics Market
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Service:
        • Manufacturing
        • Packaging and Labelling
        • Distribution
      • By End User:
        • Pharmaceutical
        • Medical Devices
        • Biologics
    • Middle East Clinical Trial Supply and Logistics Market
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Service:
        • Manufacturing
        • Packaging and Labelling
        • Distribution
      • By End User:
        • Pharmaceutical
        • Medical Devices
        • Biologics
    • Africa Clinical Trial Supply and Logistics Market
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
      • By Service:
        • Manufacturing
        • Packaging and Labelling
        • Distribution
      • By End User:
        • Pharmaceutical
        • Medical Devices
        • Biologics
  • Company Profiles
    • Catalent Pharma Solutions, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Almac Group
    • Movianto
    • Patheon, Inc.
    • PCI Pharma Services
    • Sharp Packaging services
    • PAREXEL International Corporation
    • Marken
    • KLIFO A/S
    • Biocair

*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Service
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Supply Chain Management
    • Clinical Trial Management
    • Regulatory Scenario
    • Merger and Acquisition
    • Key Developments
    • PEST Analysis
    • PORTER’s Analysis
  4. Global Clinical Trial Supply and Logistics Market, By Service, 2016–2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Manufacturing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
    • Packaging and Labeling
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
    • Distribution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
  5. Global Clinical Trial Supply and Logistics Market, By End User, 2016–2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Pharmaceutical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
    • Medical Device
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
    • Biologics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
  6. Global Clinical Trial Supply and Logistics Market, By Regions, 2016–2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2016–2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Service, 2016–2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016–2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016–2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Service, 2016–2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016–2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016–2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Service, 2016–2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016–2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016–2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Service, 2016–2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016–2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016–2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Service, 2016–2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016–2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016–2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Service, 2016–2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016–2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016–2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Catalent Pharma Solutions, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Almac Group
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Movianto
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Patheon, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • PCI Pharma Services
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Sharp Packaging Services
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • PAREXEL International Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • MARKEN
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • KLIFO A/S
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Biocair
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 25 market data tables and 44 figures on "Clinical Trial Supply and Logistics Market” - Global forecast to 2026”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.